TNS Advanced+ Serum

Before TNS, topical growth factor skincare was not a category. The original TNS Recovery Complex, launched by SkinMedica in 1999 under the direction of dermatologist Dr. Richard Fitzpatrick, was the first widely distributed topical growth factor product and the starting point for an entire corner of professional skincare. Twenty-plus years later, TNS Advanced+ is what that original idea has become: the TNS-MR platform — an updated human fibroblast conditioned media fraction — paired with Renessensce Advanced, a supporting cast of signal peptides, postbiotics, marine algae extract, and botanical stem cell extracts designed to push the same wrinkle, texture, and firmness endpoints from multiple angles at once. This is the serum the rest of the growth factor category is still, in some sense, reacting to. The formulation reads unlike most luxury serums. After water and pentylene glycol, the third ingredient is Human Fibroblast Conditioned Media — the signature TNS fraction. Shea butter ethyl esters provide a silky cushion without an oily finish. Then the serum stacks into Lactococcus ferment lysate, whey protein, chlorella extract, saccharide isomerate (a humectant), and two peptides that are doing real work — trifluoroacetyl tripeptide-2, marketed as Uplevity for its elastin effects, and dimer tripeptide-43, a Nrf2 pathway peptide that supports cellular antioxidant defense. Underneath that sit hydrolyzed linseed extract, grape flower cell extract, and apple fruit extract, all of which contribute supporting antioxidant and signaling activity. It is a remarkably dense formula, and it is structured the way SkinMedica has always built flagships: a primary active backed by several supporting actives aimed at overlapping pathways, with the formulation vehicle chosen to protect and deliver the delicate protein components. Texture-wise, it delivers immediately. The serum dispenses from the airless pump as a light cream-gel that spreads like a thin lotion and absorbs within about thirty seconds, leaving a slightly cushioned, velvety finish that sits well under any moisturizer or sunscreen. It is genuinely fragrance-free — there is a very faint neutral note that comes from the protein actives themselves, not from added scent — and tolerant of almost every skin type, including sensitive and post-procedure skin. This is one of the rare luxury serums that actually feels worth applying twice a day, which matters because compliance drives outcomes in this category more than ingredient lists do. Performance is the hard conversation. TNS is a slow builder. The first couple of weeks give you softness and plumping that is mostly hydration, and new users sometimes feel impatient waiting for the more impressive changes. Those show up further out, usually between weeks 8 and 16, as fine lines begin to soften, crepey texture smooths, and overall skin quality improves in a way that is easier to see in photos than in the mirror. SkinMedica has run several company-sponsored clinical studies on the TNS platform measuring wrinkle, texture, and tone improvements at the 12 to 24 week mark; the data is promising and consistent with what longtime users report, though it is not independent academic research and the effect sizes are modest rather than dramatic. What TNS is not is a retinol replacement. It signals from a different pathway, and users who want maximum anti-aging performance layer both — TNS in the morning, retinol at night, or TNS under retinol in the same evening routine. The two are complementary, and the combination is one of the more common derm-office recommendations for mature skin. Now the price. Two hundred and ninety-five dollars for one ounce is, on any reasonable accounting, a luxury purchase. That price is defensible in the specific context of a reader who is already investing in aesthetic procedures, who has mature skin with real anti-aging goals, and who wants a cosmetically elegant daily serum with a long and credible brand pedigree to back it up. It is not defensible as a default starter anti-aging serum for someone building their first routine. Well-formulated peptide serums and stable retinol products exist in the $30 to $80 range and will give most readers a stronger per-dollar outcome. The best case for TNS Advanced+ is as the centerpiece of an already-expensive regimen, not as the sole anti-aging product trying to justify its own sticker price. One more thing worth naming: the growth factor sourcing discussion. The TNS fraction is human fibroblast conditioned media — the molecules cultured cells secrete, not the cells themselves — and for some readers the origin story is a consideration. There is no clinical evidence linking topical growth factor serums to any increased cancer risk in cosmetic use, and the molecules are large and absorb poorly, but some dermatologists avoid recommending them to active cancer patients out of theoretical caution. If that is relevant to your situation, talk to your doctor.

Formula

The Science

Growth factors are signaling proteins that regulate cellular processes including proliferation, migration, and extracellular matrix production. In skin, fibroblast-derived growth factors help drive collagen and elastin synthesis during normal turnover and wound healing. Topical application of growth factor mixtures has been studied for cosmetic anti-aging for over two decades, with SkinMedica's TNS platform among the earliest and most consistently researched. Company-sponsored clinical trials of TNS Recovery Complex and the newer TNS Advanced+ have reported statistically significant improvements in fine lines, wrinkles, skin texture, and tone at 12 to 24 weeks of twice-daily use, with effect sizes that are meaningful but moderate rather than transformative. The peptides in the formula — trifluoroacetyl tripeptide-2 (Uplevity) and dimer tripeptide-43 — have their own small evidence bases for elastin synthesis and Nrf2 pathway activation respectively, though most published data is company or supplier research. Critics of growth factor serums have historically raised concerns about whether large protein molecules can penetrate the stratum corneum in meaningful quantities; the answer is that penetration is limited but not zero, and the mechanism of action may also involve signaling at the skin surface rather than deep delivery. Independent peer-reviewed research on topical growth factor serums remains limited compared to workhorse actives like retinoids and vitamin C, and readers should weigh that gap when interpreting claims.

Dermatologist Perspective

Dermatologists commonly recommend TNS Advanced+ as a daily anti-aging serum for patients with mature or photoaged skin, particularly those who are also undergoing in-office procedures like microneedling, fractional laser, or energy-based skin tightening. Board-certified dermatologists often note that growth factor serums like TNS work well alongside retinoids rather than replacing them, and that adherence is the biggest determinant of outcome. This product is frequently positioned as a cornerstone of the SkinMedica ecosystem and is typically paired with a vitamin C serum in the morning and a retinol complex at night. Some dermatologists express theoretical caution about growth factor serums in patients with a history of active cancer, though there is no clinical evidence of topical risk.

Guidance

SkinMedica was founded in 1999 by dermatologist Dr. Richard Fitzpatrick, and the first TNS Recovery Complex launched shortly after as one of the earliest topical growth factor serums. TNS Advanced+ arrived in 2020 as a next-generation reformulation, combining the updated TNS-MR growth factor platform with the Renessensce Advanced complex. It is the brand's flagship product and the one that dermatology offices tend to stock first.

About SkinMedica Established Brand (5–20 years)

SkinMedica was founded in 1999 by dermatologist Dr. Richard Fitzpatrick around the original TNS growth factor platform, now owned by Allergan Aesthetics. The TNS technology has been the subject of multiple company-sponsored clinical trials measuring improvements in wrinkle and skin texture scores, and the serum line is extensively distributed through US dermatology practices.

Brand founded: 1999 · Product launched: 2020

Myth vs. Reality

Myth

Growth factors in skincare can cause cancer.

Reality

The growth factor fraction in topical serums is not the same as systemic growth factor therapy. The molecules are large and absorb poorly, and there is no clinical evidence linking topical growth factor serums to any increased cancer risk in cosmetic use. Some dermatologists still avoid recommending them to patients with active cancer out of theoretical caution.

Myth

TNS is a stem cell product.

Reality

TNS is a conditioned media product — it contains the proteins, growth factors, and signaling molecules secreted by cultured human fibroblasts, not the cells themselves. There are no live stem cells in the serum.

FAQ

Common Praise

"Visible improvement in fine lines and crepey texture over months of use"

"Dramatically plumper, smoother skin appearance"

"Elegant, non-greasy texture"

"Tolerated by sensitive skin"

"Pairs well with retinol without added irritation"

Common Complaints

"One of the most expensive serums on the market"

"Results are slow — not a fast fix"

"Growth factor sourcing raises questions for some users"

"Pump can be temperamental near the end of the bottle"

Notable Endorsements

Flagship of SkinMedica's professional skincare lineFrequently recommended by US dermatologists for mature skin and post-procedure supportFeatured in aesthetic-practice conferences

Appears In

best growth factor serum best anti aging serum for mature skin best dermatologist serum best luxury anti aging serum

Related Conditions

aging sun damage texture dullness

Related Ingredients

growth factors peptides chlorella fermented extract